Low grade fibromyxoid sarcoma of the perineum: a surgical challenge
DOI:
https://doi.org/10.18203/2349-2902.isj20164486Keywords:
Deceptively benign, Immunohistochemistry, Late metastasis, Local recurrence, Low grade fibromyxoid sarcoma, LGFMS, Perineum, Wide surgical excisionAbstract
Low-grade fibromyxoid sarcoma is a rare, slow growing and deceptively benign-appearing neoplasm. It is presently diagnosed on the basis of histopathology (typical fibro-myxoid appearance), immunohistochemistry (vimentin staining) and cytogenetics [chimeric FUS/CREB3L2 gene produced by t (7;16), (q33;p11)]. This tumour should be differentiated from other resembling tumours like myxofibrosarcoma, sclerosing epitheloid fibrosarcoma, desmoid fibromatosis and others. It has the potential for local recurrence and late metastasis, if not treated adequately. Although surgical excision is the only hope for treatment, reporting of details of surgical management have often been neglected for this primarily pathological entity. We report a case of a 30-year female who had a perineal mass which was managed by wide surgical excision. It was diagnosed as low-grade fibromyxoid sarcoma on the basis of histopathology and immunohistochemistry. This extremely rare presentation is, thus, discussed in context of challenging nature of its surgical excision. Patient is in follow-up and has no recurrence even after 5 years.
Metrics
References
Evans HL. Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. 1987;88(5):615-9.
Vernon SE, Bejarano PA. Low-grade fibromyxoid sarcoma: a brief review. Arch Pathol Lab Med. 2006;130(9):1358-60.
Zamecnik M, Michal M. Low-grade fibromyxoid sarcoma: a report of eight cases with histologic, immunohistochemical, and ultra structural study. Ann Diagn Pathol. 2000;4(4):207-17.
Nielsen MK, Baerentzen S, Keller J, Dyrop HB, Safwat A. Low-grade fibromyxoid sarcoma: Incidence, treatment strategy of metastases, and clinical significance of the FUS gene. Sarcoma. 2013:256280.
Billing SD, Giblen G, Smith JC. Superficial low grade fibromyxoid sarcoma (evan tumour): a clinicopathological analysis of 19 cases with a unique observation in the pediatric population. Am J Surg Pathol. 2005;29(2):204-10.
Folpe AL, Lane KL, Paull G, Weiss SW. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. Am J Surg Pathol. 2000;24:1353-60.
Goodlad JR, Mentzel T, Fletcher CD. Low grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity. Histopathology. 1995;26:229-37.
Evans HL. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up. Am J Surg Pathol. 2011;35(10):1450-62.
Kim SY, Kim M, Hwanj YJ, Han YH, Seo JW, Kim YH, et al. Low-grade fibromyxoid sarcoma CT, sonography, and MR findings in 3 cases. J Thorac Imaging. 2005;20:294-7.
Panagopoulos I, Storlazzi CT, Fletcher C. The chimeric FUS/CREB3L2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer. 2004;40:218-28.
Reid R, Silva MV, Paterson L. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16) (q34;p11) translocation. Am J Surg Pathol. 2013;27:1229-36.